Literature DB >> 3254809

Pleomorphic carcinoma of the pancreas with osteoclast-like giant cells expressing an epithelial-associated antigen detected by monoclonal antibody 44-3A6.

S G Combs1, D F Hidvegi, Y Ma, S T Rosen, J A Radosevich.   

Abstract

This article describes a case of pleomorphic adenocarcinoma of the pancreas, metastatic to the adrenal glands and liver, that has unique cytological and histological features. Cytology demonstrated numerous mononuclear and multinucleated tumor giant cells as well as numerous osteoclast-like giant cells. These features were also seen in the histological sections, as were numerous clear cells. Electron microscopy demonstrated features suggesting an epithelial origin of the epulis cells. Prominent immunoreactivity with the monoclonal antibody (MCA) 44-3A6 of these cellular constituents was seen in the aspirate and in the tissue sections. These data provide further evidence to support the epithelial origin of these cellular components.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3254809     DOI: 10.1002/dc.2840040409

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  6 in total

Review 1.  My approach to pancreatic fine needle aspiration.

Authors:  Gladwyn Leiman
Journal:  J Clin Pathol       Date:  2006-05-12       Impact factor: 3.411

2.  Mixed pleomorphic-osteoclast-like tumor of the pancreas. Light microscopical, immunohistochemical, and molecular biological studies.

Authors:  B Gatteschi; S Saccomanno; F G Bartoli; S Salvi; G Liu; V Pugliese
Journal:  Int J Pancreatol       Date:  1995-10

3.  Pleomorphic carcinoma of the pancreas with osteoclast-like giant cells.

Authors:  T Nojima; F Nakamura; M Ishikura; K Inoue; K Nagashima; H Kato
Journal:  Int J Pancreatol       Date:  1993-12

Review 4.  Metastatic Carcinoma in Effusions.

Authors:  Vinod B Shidham
Journal:  Cytojournal       Date:  2022-01-31       Impact factor: 2.345

Review 5.  Labyrinthin, The Tumor Marker Recognized By MCA 44-3A6: A Case For Pan-Tumor Markers As Targets To Treat Cancer.

Authors:  James A Radosevich; Michael Babich
Journal:  Onco Targets Ther       Date:  2019-11-06       Impact factor: 4.147

6.  Labyrinthin: A distinct pan-adenocarcinoma diagnostic and immunotherapeutic tumor specific antigen.

Authors:  Michael Babich; Ankit Sharma; Tianhong Li; James A Radosevich
Journal:  Heliyon       Date:  2022-02-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.